Paper17564969
RNA interference-mediated suppression and replacement of human rhodopsin in vivo.
O'Reilly M and 15 others. Am J Hum Genet, 2007. Cited by 146 papers, by iCite.
Cite this record
ConductScience Library. RNA interference-mediated suppression and replacement of human rhodopsin in vivo. Papers, record 17564969. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17564969
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genetic Therapy | Major topic |
| RNA Interference | Major topic |
| Retinitis Pigmentosa | Major topic |
| Rhodopsin | Major topic |
| Suppression, Genetic | Major topic |
| Adenoviridae | |
| Animals | |
| Base Sequence | |
| HeLa Cells | |
| Humans | |
| Mice | |
| Mice, Transgenic | |
| Molecular Sequence Data | |
| RNA, Small Interfering | |
| Retina |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| TGM03P04 | Telethon | Italy | PubMed | |
| TGM06S01 | Telethon | Italy | PubMed |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11029552 | Ribozyme uses in retinal gene therapy. | Prog Retin Eye Res | 2000 | https://conductscience.org/library/papers/11029552 | PubMed |
| 2 | 17223737 | AAV-mediated gene transfer for retinal diseases. | Expert Opin Biol Ther | 2006 | https://conductscience.org/library/papers/17223737 | PubMed |
| 3 | 11373684 | Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. | Nature | 2001 | https://conductscience.org/library/papers/11373684 | PubMed |
| 4 | 11390622 | Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. | J Virol | 2001 | https://conductscience.org/library/papers/11390622 | PubMed |
| 5 | 11867514 | On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention. | EMBO J | 2002 | https://conductscience.org/library/papers/11867514 | PubMed |
| 6 | 11910072 | A system for stable expression of short interfering RNAs in mammalian cells. | Science | 2002 | https://conductscience.org/library/papers/11910072 | PubMed |
| 7 | 12367732 | Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR. | J Virol Methods | 2002 | https://conductscience.org/library/papers/12367732 | PubMed |
| 8 | 12954115 | Coupling of RNAi-mediated target downregulation with gene replacement. | Antisense Nucleic Acid Drug Dev | 2003 | https://conductscience.org/library/papers/12954115 | PubMed |
| 9 | 14603031 | Electroporation and RNA interference in the rodent retina in vivo and in vitro. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/14603031 | PubMed |
| 10 | 14750605 | Gene therapy for Leber congenital amaurosis. | Novartis Found Symp | 2004 | https://conductscience.org/library/papers/14750605 | PubMed |
| 11 | 15235598 | RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. | Nat Med | 2004 | https://conductscience.org/library/papers/15235598 | PubMed |
| 12 | 15241481 | RNAi of COL1A1 in mesenchymal progenitor cells. | Eur J Hum Genet | 2004 | https://conductscience.org/library/papers/15241481 | PubMed |
| 13 | 15454954 | Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives. | Gene Ther | 2004 | https://conductscience.org/library/papers/15454954 | PubMed |
| 14 | 1418997 | Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa. | Neuron | 1992 | https://conductscience.org/library/papers/1418997 | PubMed |
| 15 | 9020854 | Retinopathy induced in mice by targeted disruption of the rhodopsin gene. | Nat Genet | 1997 | https://conductscience.org/library/papers/9020854 | PubMed |
| 16 | 9254694 | Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. | Nucleic Acids Res | 1997 | https://conductscience.org/library/papers/9254694 | PubMed |
| 17 | 9285777 | Strategems in vitro for gene therapies directed to dominant mutations. | Hum Mol Genet | 1997 | https://conductscience.org/library/papers/9285777 | PubMed |
| 18 | 9499080 | Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. | J Virol | 1998 | https://conductscience.org/library/papers/9499080 | PubMed |
| 19 | 9701253 | Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. | Nat Med | 1998 | https://conductscience.org/library/papers/9701253 | PubMed |
| 20 | 10369877 | Structural and functional rescue of murine rod photoreceptors by human rhodopsin transgene. | Hum Mol Genet | 1999 | https://conductscience.org/library/papers/10369877 | PubMed |
Cited by87
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 146 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42931621 | Retinitis Pigmentosa: A Review of Its Pathogenesis and Emerging Molecular and Cellular Therapies. | Vision (Basel) | 2026 | https://conductscience.org/library/papers/42931621 | PubMed |
| 40731809 | Retinitis Pigmentosa: From Genetic Insights to Innovative Therapeutic Approaches-A Literature Review. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/40731809 | PubMed |
| 39201561 | AAV-NDI1 Therapy Provides Significant Benefit to Murine and Cellular Models of Glaucoma. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39201561 | PubMed |
| 38108516 | CRISPRi-Mediated Treatment of Dominant Rhodopsin-Associated Retinitis Pigmentosa. | CRISPR J | 2023 | https://conductscience.org/library/papers/38108516 | PubMed |
| 36935427 | Gene augmentation for autosomal dominant retinitis pigmentosa using rhodopsin genomic loci nanoparticles in the P23H+/- knock-in murine model. | Gene Ther | 2023 | https://conductscience.org/library/papers/36935427 | PubMed |
| 36839646 | Optimisation of AAV-NDI1 Significantly Enhances Its Therapeutic Value for Correcting Retinal Mitochondrial Dysfunction. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36839646 | PubMed |
| 36311029 | G protein-coupled receptors in cochlea: Potential therapeutic targets for hearing loss. | Front Mol Neurosci | 2022 | https://conductscience.org/library/papers/36311029 | PubMed |
| 36096547 | Therapeutic Gene Editing in Inherited Retinal Disorders. | Cold Spring Harb Perspect Med | 2023 | https://conductscience.org/library/papers/36096547 | PubMed |
| 34768969 | The Next Generation of Molecular and Cellular Therapeutics for Inherited Retinal Disease. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34768969 | PubMed |
| 34722588 | Gene Therapy in Inherited Retinal Diseases: An Update on Current State of the Art. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34722588 | PubMed |
| 34445243 | Nanotechnology-Based Strategies to Overcome Current Barriers in Gene Delivery. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445243 | PubMed |
| 34400638 | Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa. | Nat Commun | 2021 | https://conductscience.org/library/papers/34400638 | PubMed |
| 33324145 | Optimized OPA1 Isoforms 1 and 7 Provide Therapeutic Benefit in Models of Mitochondrial Dysfunction. | Front Neurosci | 2020 | https://conductscience.org/library/papers/33324145 | PubMed |
| 33261050 | Properties and Therapeutic Implications of an Enigmatic D477G RPE65 Variant Associated with Autosomal Dominant Retinitis Pigmentosa. | Genes (Basel) | 2020 | https://conductscience.org/library/papers/33261050 | PubMed |
| 32973439 | AAV-Delivered Tulp1 Supplementation Therapy Targeting Photoreceptors Provides Minimal Benefit in Tulp1-/- Retinas. | Front Neurosci | 2020 | https://conductscience.org/library/papers/32973439 | PubMed |
| 32882181 | Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa. | Mol Ther | 2020 | https://conductscience.org/library/papers/32882181 | PubMed |
| 32531192 | Modeling and Rescue of RP2 Retinitis Pigmentosa Using iPSC-Derived Retinal Organoids. | Stem Cell Reports | 2020 | https://conductscience.org/library/papers/32531192 | PubMed |
| 32120883 | Metabolic and Redox Signaling of the Nucleoredoxin-Like-1 Gene for the Treatment of Genetic Retinal Diseases. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32120883 | PubMed |
| 31884598 | Progress in Gene Therapy for Rhodopsin Autosomal Dominant Retinitis Pigmentosa. | Adv Exp Med Biol | 2019 | https://conductscience.org/library/papers/31884598 | PubMed |
| 31853424 | Systematic Screening, Rational Development, and Initial Optimization of Efficacious RNA Silencing Agents for Human Rod Opsin Therapeutics. | Transl Vis Sci Technol | 2019 | https://conductscience.org/library/papers/31853424 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| RHO | 6010 | PubTator's text mining | https://conductscience.org/library/genes/6010 |
Source NCBI Gene
Data2
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17564969
GET https://conductscience.org/api/papers/v1/17564969/references?page=2